SIGA Technologies
SIGA
$8.76
Share price
-0.34%
Change (1 day)
50.26%
Change (1 year)
Categories
SIGA Technologies (SIGA) - Total debt
Total debt on the balance sheet as of December 2023 : $0.56 M
According to SIGA Technologies's latest financial reports the company's total debt is $0.56 M. A company’s total debt is the sum of all current and non-current debts.
SIGA Technologies - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.56 M | 6.79% |
| 2022-12-31 | $0.52 M | 13.14% |
| 2021-12-31 | $0.46 M | 3.75% |
| 2020-12-31 | $0.44 M | -99.44% |
| 2019-12-31 | $80.46 M | 6.51% |
| 2018-12-31 | $75.54 M | 6.33% |
| 2017-12-31 | $71.05 M | 6.76% |
| 2016-12-31 | $66.55 M | |
| 2014-12-31 | $1.98 M | -49.73% |
| 2013-12-31 | $3.95 M | -19.37% |
| 2012-12-31 | $4.91 M | |
| 2006-12-31 | $0.13 M | -39.16% |
| 2005-12-31 | $0.21 M | |
| 2002-12-31 | $0.01 M | -94.17% |
| 2001-12-31 | $0.19 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $1.39 B | 247,557.40% | 🇺🇸 USA |
 Novavax NVAX | $0.22 B | 40,516.55% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $2.54 M | 350.70% | 🇺🇸 USA |
 NanoViricides NNVC | $1.5 M | 165.95% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | $0.82 B | 146,200.50% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $0.86 B | 152,415.30% | 🇺🇸 USA |